Fig. 4
From: A 4-gene signature predicts prognosis of uterine serous carcinoma
Validation of the 4-gene signature in predicting recurrence-free survival (RFS) in the TCGA dataset. a-c The distribution of risk score, RFS, and survival status and the 4 genes expression patterns for the 95 patients with RFS data. d Kaplan–Meier analysis compares RFS between patients in the high- and low-risk group. e ROC analysis of the 4-gene signature and other clinicopathological parameters (age, invasion, node metastasis and stage) for prediction RFS. f Kaplan-Meier analysis compares RFS between patients in the high- and low-risk group in late stage (III + IV) patients